US EditionNIH Grant Cuts Will Axe Clinical Trials Abroad — And Could Leave Thousands Without Care - Data Intelligence
Summary by Plato. Vertical Search. Ai. | PlatoAiStream. Data Intelligence. Vertical Search. Ai.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
NIH Grant Cuts Will Axe Clinical Trials Abroad — And Could Leave Thousands Without Care - Data Intelligence
Diseases caused by HIV and drug-resistant tuberculosis could surge globally as a result of research-grant cuts made by the US National Institutes of Health. Credit: Jekesai Njikizana/AFP via Getty Amita Gupta has spent more than a decade planning and running a US$70-million trial to study a new tuberculosis drug, enrolling nearly 6,000 participants across 13 countries. It might all have been for nothing. Gupta’s trial has been ensnared by a US …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
